Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Proximity biotin labelling identification (BioID) analysis of Bcl-2 protein interactions in live cells.

Created on 17 Nov 2026

Authors

Charlotte E L Mellor, Andrew P Gilmore

Published in

Methods in cell biology. Volume 211. Pages 25-44. Epub Jun 08, 2026.

Abstract

Bcl-2 proteins are the central regulators of the intrinsic pathway of apoptosis. The multidomain pro-apoptotic members of the family, Bax and Bak, oligomerise to form large pores in the outer mitochondrial membrane (OMM) to initiate cell death. This process is antagonised by antiapoptotic Bcl-2 proteins such as Bcl-2, Bcl-XL and Mcl-1. The BH3-only subgroup of the Bcl-2 family interact with both the pro- and anti-apoptotic proteins to promote OMM permeabilization, either by directly activating Bax and Bak, or by inhibiting the anti-apoptotic proteins. The overall level of interaction and expression of these different subsets of Bcl-2 proteins sets the threshold for MOMP, termed apoptotic or mitochondrial priming. Adding further to the complexity are a multitude of what could be termed non-canonical interactions reported in the literature which can influence Bcl-2 proteins. Investigating these interactions in live cells is therefore important to gain a holistic understanding of how apoptosis is regulated. Here we describe approaches to use proximity biotin labelling identification (BioID) to study in situ interactions of Bcl-2 proteins.

PMID:
43039470
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement